3qct
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | [[Image:3qct.jpg|left|200px]] | |
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3qct", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3qct| PDB=3qct | SCENE= }} | ||
- | + | ===Crystal structure of the humanized apo LT3015 anti-lysophosphatidic acid antibody Fab fragment=== | |
- | + | ||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_21392506}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 21392506 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_21392506}} | ||
+ | |||
+ | ==About this Structure== | ||
+ | [[3qct]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3QCT OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:21392506</ref><references group="xtra"/> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Campbell, M A.]] | ||
+ | [[Category: Fleming, J K.]] | ||
+ | [[Category: Huxford, T.]] | ||
+ | [[Category: Wojciak, J M.]] |
Revision as of 08:06, 30 March 2011
Crystal structure of the humanized apo LT3015 anti-lysophosphatidic acid antibody Fab fragment
Template:ABSTRACT PUBMED 21392506
About this Structure
3qct is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Fleming JK, Wojciak JM, Campbell MA, Huxford T. Biochemical and Structural Characterization of Lysophosphatidic Acid Binding by a Humanized Monoclonal Antibody. J Mol Biol. 2011 Mar 24. PMID:21392506 doi:10.1016/j.jmb.2011.02.061